Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

ClinicalTrials.gov ID: NCT04864392

Public ClinicalTrials.gov record NCT04864392. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 5-year, Randomized, Double-blind, Placebo-controlled, Multi-center Study Assessing the Efficacy, Safety, and Tolerability of Intra-articular Regimens of LNA043 Versus Placebo in Patients With Symptomatic Knee Osteoarthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This was a multicenter, randomized, double-blind, placebo-controlled Phase IIb study evaluating intra-articular LNA043 in patients with knee osteoarthritis.

Study identification

NCT ID
NCT04864392
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
576 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2021 (Actual)
Primary completion
Sep 29, 2024 (Actual)
Completion
May 29, 2025 (Actual)
Last update posted
Apr 2, 2026

2021 – 2025

United States locations

U.S. sites
23
U.S. states
12
U.S. cities
23
Facility City State ZIP Site status
Elite Clinical Studies Phoenix Arizona 85018 —
Tucson Orthopedic Institute PC Tucson Arizona 85712 —
Sharps Hospital Grossmont La Mesa California 91942 —
Clinical Trials Research Lincoln California 95648 —
Long Beach Clinical Trials Long Beach California 90806 —
Artemis Institute Clinical Research Riverside California 92503 —
Northern California Research Sacramento California 95821 —
Arthemis Clinical Research San Diego California 92103 —
Stamford Therapeutics Consortium LLC Stamford Connecticut 06905 —
Sensible Healthcare Ocoee Florida 34761 —
Clinical Research of West Florida Inc Tampa Florida 33603 —
Conquest Research Winter Park Florida 32789 —
Chicago Clinical Research Inst Chicago Illinois 60607 —
Tandem clinical research Marrero Louisiana 70072 —
The Center for Rheumatology and Bone Research Wheaton Maryland 20902 —
Center For Pharmaceutical Research Kansas City Missouri 64114 —
Drug Trials America Hartsdale New York 10530 —
AMR Knoxville Knoxville Tennessee 37920 —
Metroplex Clinical Research Dallas Texas 75231 —
Pioneer Research Solutions Sugar Land Texas 77479 —
Charlottesville Medical Research Charlottesville Virginia 22911 —
Annapolis Rheumatology LLC Fairfax Virginia 22033 —
Virginia Ispine Physicians PC Richmond Virginia 23238 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04864392, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04864392 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →